TANG CAPITAL MANAGEMENT LLC
Top Portfolio Positions
50 positions ·
$1,989,414,082 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
12,229,500 | $181,241,190 | 9.11% | |
| CELC |
Celcuity Inc.
Healthcare
|
1,050,000 | $119,847,000 | 6.02% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
1,236,027 | $114,184,174 | 5.74% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
3,785,991 | $113,579,730 | 5.71% | |
| SPY |
Spdr S&P 500 ETF Trust
|
168,000 | $109,257,120 | 5.49% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
2,259,889 | $108,813,655 | 5.47% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
3,399,900 | $103,356,960 | 5.20% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
1,500,000 | $102,195,000 | 5.14% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
1,892,200 | $95,442,568 | 4.80% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
4,573,530 | $92,065,158 | 4.63% |
Portfolio Trend
25 quarters · across all stocks
Holdings in SYRE
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,442,568 | 1,892,200 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $61,988,472 | 1,892,200 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $61,988,472 | 1,892,200 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $53,632,000 | 3,200,000 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $47,904,000 | 3,200,000 | Shares | Other | 2025-08-14 | |
| 2025-04-24 | $47,776,000 | 3,200,000 | Shares | Sole | 2025-05-01 | |
| 2025-03-31 | $33,076,750 | 2,050,000 | Shares | Other | 2025-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||